You have 9 free searches left this month | for more free features.

metastatic malignant peripheral nerve sheath tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

Recruiting
  • Peripheral Nerve Sheath Tumor
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Pharmacodynamic Study
  • Telaglenastat Hydrochloride
  • Birmingham, Alabama
  • +30 more
Sep 1, 2022

Nerve Origin of Neck Peripheral Nerve Sheath Tumors

Recruiting
  • Peripheral Nerve Sheath Tumors
  • Schwannoma of Neck
  • Excision
  • Taipei, Taiwan
    National Cheng-Kung University Hospital
Jan 12, 2023

Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)

Completed
  • Neurofibromatosis
  • MPNST
  • MRI, FDG-PET/CT scans
  • [18F]-FLT-PET/CT scans
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Development to Predict Malignant Conversion in Neurofibromatosis

Recruiting
  • Neurofibromatosis 1
  • +2 more
  • Whole Body Magnetic Resonance Imaging
  • Baltimore, Maryland
    Johns Hopkins University
Dec 22, 2022

Malignant Peripheral Nerve Sheath Tumors (MPNST) Trial in United States (ASTX727)

Recruiting
  • Malignant Peripheral Nerve Sheath Tumors (MPNST)
  • Basking Ridge, New Jersey
  • +6 more
Aug 25, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

Recruiting
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors
  • Iowa City, Iowa
  • +4 more
Aug 26, 2021

Malignant Peripheral Nerve Sheath Tumor Development in

Active, not recruiting
  • Neurofibromatosis 1
  • Peripheral Nerve Neoplasms, Malignant
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor

    Recruiting
    • Metastatic Malignant Peripheral Nerve Sheath Tumor
    • +2 more
    • Computed Tomography
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 6, 2022

    Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

    Recruiting
    • Wilms Tumor
    • +6 more
    • Los Angeles, California
    • +10 more
    Aug 2, 2023

    Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors Trial in Shanghai (AL2846 capsules)

    Recruiting
    • Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
    • AL2846 capsules
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, School of Medicine, Shanghai J
    Sep 24, 2021

    Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

    Recruiting
    • Soft Tissue Sarcoma
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Malignant Peripheral Nerve Sheath Tumour (MPNST) Trial in Oslo (Pembrolizumab)

    Terminated
    • Malignant Peripheral Nerve Sheath Tumour (MPNST)
    • Oslo, Norway
      Oslo university Hospital
    Jun 21, 2021

    Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

    Recruiting
    • Sarcoma,Soft Tissue
    • Tenerife, Canarias, Spain
    • +10 more
    Oct 27, 2023

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

    Recruiting
    • Desmoplastic Small Round Cell Tumor
    • +11 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 26, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

    Available
    • Pancreatic Cancer
    • +6 more
    • Santa Monica, California
      Sarcoma Oncology Research Center, LLC
    Jan 20, 2022

    Type I Neurofibromatosis Trial in Shanghai (TQ-B3234 capsule)

    Not yet recruiting
    • Type I Neurofibromatosis
    • TQ-B3234 capsule
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital ,Shanghai JiaoTong University S
    Oct 22, 2021

    MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

    Not yet recruiting
    • MPNST
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Jun 29, 2022